UBS Group
PRTC

UBS Group’s PureTech Health PRTC Stock Holding History

UBS Group’s Portfolio PRTC Stock Details PRTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$297 Hold
20
– – ﹤0.01% 9971
2025
Q4 		$334 Hold
20
– – ﹤0.01% 10025
2025
Q3 		$370 Hold
20
– – ﹤0.01% 9713
2025
Q2 		$345 Hold
20
– – ﹤0.01% 9862
2025
Q1 		$396 Sell
20
-1,883
-99% -$34.4K ﹤0.01% 9795
2024
Q4 		$35.1K Buy
1,903
+1,256
+194% +$26.3K ﹤0.01% 7513
2024
Q3 		$13.3K Buy
647
+296
+84% +$6.47K ﹤0.01% 7591
2024
Q2 		$8.78K Buy
351
+331
+1,655% +$9.27K ﹤0.01% 7780
2024
Q1 		$570 Hold
20
– – ﹤0.01% 8468
2023
Q4 		$564 Sell
20
-8
-29% -$163 ﹤0.01% 8587
2023
Q3 		$644 Buy
28
+8
+40% +$215 ﹤0.01% 8357
2023
Q2 		$570 Sell
20
-1
-5% -$28 ﹤0.01% 8176
2023
Q1 		$609 Buy
21
+1
+5% +$30 ﹤0.01% 8958
2022
Q4 		$638 Hold
20
– – ﹤0.01% 10112
2022
Q3 		$1K Sell
20
-349
-95% -$9.2K ﹤0.01% 10010
2022
Q2 		$7K Buy
369
+349
+1,745% +$8.01K ﹤0.01% 8517
2022
Q1 		$1K Hold
20
– – ﹤0.01% 9905
2021
Q4 		$1K Hold
20
– – ﹤0.01% 10017
2021
Q3 		$1K Sell
20
-43
-68% -$2.09K ﹤0.01% 9226
2021
Q2 		$3K Sell
63
-66
-51% -$3.55K ﹤0.01% 8833
2021
Q1 		$7K Sell
129
-96
-43% -$5.36K ﹤0.01% 8162
2020
Q4 		$12K Buy
+225
New +$9.99K ﹤0.01% 7350

Other funds holding PRTC

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return

UBS Group's PRTC Position: Q1 2026 in Review

UBS Group held its PureTech Health (PRTC) position steady in Q1 2026 at 20 shares worth $297. The position accounts for ﹤0.01% of the portfolio, ranked #9971.

UBS Group first reported a position in PRTC in Q4 2020 and has held it in 22 quarters since. The position peaked at $35.1K in Q4 2024. 5 funds tracked by Wall St. Rank hold PRTC as of Q1 2026.

  • UBS Group held 20 shares of PureTech Health worth $297 as of Q1 2026.
  • UBS Group left its PureTech Health share count unchanged in Q1 2026.
  • PureTech Health made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9971 holding.
  • UBS Group first reported a position in PureTech Health in Q4 2020 and has held it in 22 quarters since.
  • UBS Group's PureTech Health position peaked at $35.1K in Q4 2024.
  • 5 funds tracked by Wall St. Rank held PureTech Health as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.